Clinical Trial Update: A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for SHR-A1811 in advanced non-small cell lung cancer (Phase 1/Phase 2). The study is sponsored by Jiangsu HengRui Medicine Co., Ltd. and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING